Retrospective Comparison of Hematopoietic Stem Cell Transplantation Following Reduced-Intensity Conditioning with Fludarabine/Low-Dose Melphalan plus 4 Gy TBI versus Fludarabine/ Busulfan plus 4 Gy TBI

The authors evaluated the effect of reducing the melphalan dose and retrospectively compared transplant outcomes in 156 patients who received FB2 (n = 103) or FM80 (n = 53) at the center (median age: 63 years; range 27–72 years).